News & Views
Novel cancer treatment identified
Nov 08 2011
Posted by Ben Evens
Scientists have made a breakthrough in pioneering work for the treatment of cancer.
ImmunAid Pty have been awarded a European patent for its work with cancer, which involved monitoring the immune cycle of individual patients to determine the best time to administer treatment.
"The discovery of the regulated immune response cycle in cancer patients is potentially of immense clinical significance with profound public health implications," Dr Svetomir Markovic, chair of the Melanoma Group at Mayo Clinic in Rochester, Minnesota.
Research by the scientists determined that the immune system of all cancer patients moves in a repeating cycle, highlighting that administering treatment at key points in this cycle can significantly improve their clinical outcome.
Further investigation is underway into the cyclic treatment process, including into other types of cancer as well as diseases such as multiple sclerosis and human immunodeficiency virus (HIV).
Recently, researchers at the University of Texas MD Anderson Cancer Center found that a key protein plays a surprising role in cancer formation.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK